FDA advisers recommend 2nd coronavirus vaccine, with agency approval expected soon
A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.
Over-the-counter home test for COVID-19 gets federal approval
A spokesperson for Australian manufacturer Ellume said the test will be priced around $30 and be available at pharmacies and for purchase online.
Watch live: FDA advisory panel meets to review Pfizer vaccine for distribution
Pfizer’s COVID-19 vaccine faces one final hurdle as it races to become the first shot greenlighted in the U.S.: a panel of experts who will scrutinize the company’s data for any red flags.
Pfizer vaccine moves closer to getting the OK in the US
Documents released by U.S. regulators Tuesday confirmed that Pfizer’s vaccine was strongly protective against COVID-19 and appeared safe.
FDA publishes vaccine guidelines initially blocked by White House
The Food and Drug Administration released updated safety standards Tuesday for makers of COVID-19 vaccines after the White House blocked their formal release, the latest political tug-of-war between the Trump administration and the government’s public health scientists.
Government outlines sweeping plan to provide free COVID-19 vaccines
The whole enterprise is facing public skepticism. Only about half of Americans said they’d get vaccinated in one poll.
Teenage vaping falls dramatically in U.S., report says
Experts think last year’s outbreak of vaping related illnesses and deaths may have scared off some kids, but they believe higher age limits and flavor bans also contributed.
FDA chief apologizes for overstating benefits of plasma treatment on coronavirus infections
Scientists and medical experts have been pushing back against the claims about the treatment since President Trump's announcement Sunday that the FDA had decided to issue emergency authorization for convalescent plasma.
Fauci optimistic COVID-19 vaccine will be widely available to Americans in 2021
There will be a priority list for who gets early vaccinations. "I don't think we will have everybody getting it immediately," Fauci told a congressional committee.
FDA approves use of drug shown to help virus recovery for severe cases
Preliminary results from a study showed that the drug, remdesivir, shortened the time to recovery by 31% for hospitalized patients.
US virus testing faces new headwind: Lab supply shortages
The shortages are the latest stumble in a botched effort to track the spread of coronavirus that has left the U.S. weeks behind many other developed countries.
Juul halts sales of fruit, dessert flavors for e-cigarettes
Juul Labs stopped selling fruit and dessert flavors Thursday, acknowledging the public’s “lack of trust” in the vaping industry.